New Zealand clamps down on 'legal' highs

New Zealand introduced a new law on Thursday which bans the use of drugs offering so-called "legal" highs unless manufacturers can provide clinical evidence that they are safe.

The law imposes strict controls on products such as synthetic and legal "party pills", which mimic the effects of drugs like without using illicit substances.

"These products have had a shocking effect on young people and their families," Associate Health Minister Todd McClay said.

"Up until now, frontline officers have had to deal with the consequences," he continued. "Now police can be proactive, and with the help of the public we can ensure that this new law is successfully enforced."

McClay said he had received accounts of children as young as 11 becoming addicted to the , but New Zealand's "world-leading" legislation would address the problem.

"The sooner this dangerous muck is out of our dairies (newsagents) and corner stores the better," he said.

Previously, authorities had to prove a synthetic drug was harmful before ordering it off the shelves.

Under the new law, all synthetic will be illegal until their producers can provide clinical proof, such as toxicology reports and evidence from trial studies, that they are safe.

The department of health has estimated that carrying out such tests will cost manufacturers up to NZ$2 million ($1.6 million) for each synthetic , effectively deterring them from trying to sell such substances in New Zealand.

The law also stops the products being sold to minors and bans them from easily accessible retail outlets such as service stations and convenience stores.

add to favorites email to friend print save as pdf

Related Stories

Australia cracks down on synthetic drugs

Jun 16, 2013

Australia imposed an interim ban on 19 synthetic cannabis and cocaine-like drugs on Sunday as part of a crackdown on the psychoactive substances which mimic the highs of their illegal counterparts.

EU drugs watchdog warns of 'legal highs' surge

Nov 15, 2011

The rapid emergence of synthetic new drugs, often sold online as "legal highs," represents a significant challenge for policy makers in the coming decade, a European Union drugs agency said Tuesday.

Recommended for you

ER visits on the rise, study reports

5 hours ago

(HealthDay)—The number of emergency department visits in the United States rose from about 130 million in 2010 to a record 136 million in 2011, according to the U.S. Centers for Disease Control and Prevention.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.